We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Evaluates oral infigratinib on growth outcomes in children with achondroplasia, suggesting potential benefits.
No takes yet. Share an insight, caveat, or question.
Savarirayan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: